Ilhwan Yeo1, Hasan Ahmad2, Wilbert S Aronow2. 1. Division of Hospital Medicine, Department of Medicine, The Mount Sinai Hospital, New York, NY, USA. 2. Cardiology Division, Department of Medicine, Westchester Medical Center and New York Medical College, Valhalla, NY, USA.
Abstract
BACKGROUND: Sleep apnea is associated with worse outcomes following various kinds of surgeries. There is a paucity of data on the association of sleep apnea with clinical outcomes after transcatheter aortic valve replacement (TAVR). METHODS: We used National Inpatient Sample (NIS) data 2011-2014 to identify patients undergoing TAVR. Association between sleep apnea and in-hospital postoperative outcomes were assessed by multivariate logistic regression and 1:1 propensity score matching analyses. RESULTS: Of 42,189 patients who received TAVR, 4,605 patients (10.9%) had sleep apnea. Patients with sleep apnea were more likely to be younger and male with higher prevalences of hypertension, diabetes mellitus, dyslipidemia, chronic kidney disease, pulmonary hypertension and obesity who less frequently received transapical access than those without sleep apnea. The group with sleep apnea had less bleeding requiring transfusion (8.6% vs. 11.9%, P=0.01) than the counterpart. After adjusting for confounders, the presence of sleep apnea was no longer independently associated with any of the studied outcomes including all-cause mortality (OR 0.95; 95% CI: 0.64-1.42), stroke (OR 1.08; 95% CI: 0.65-1.81), myocardial infarction (OR 0.66; 95% CI: 0.36-1.22), acute respiratory failure (OR 0.94; 95% CI: 0.72-1.23), pneumothorax (OR 0.64; 95% CI: 0.26-1.59), vascular complication (OR 0.91; 95% CI: 0.69-1.22), bleeding requiring transfusion (OR 0.85; 95% CI: 0.65-1.11), acute kidney injury requiring hemodialysis (OR 0.94; 95% CI: 0.53-1.66) and permanent pacemaker implantation (OR 1.12; 95% CI: 0.87-1.43). The length and cost of hospital stay were not affected by sleep apnea, either. CONCLUSIONS: With a prevalence of 10.9%, the presence of sleep apnea was not independently associated with postoperative in-hospital outcomes in patients undergoing TAVR in NIS data 2011 to 2014.
BACKGROUND:Sleep apnea is associated with worse outcomes following various kinds of surgeries. There is a paucity of data on the association of sleep apnea with clinical outcomes after transcatheter aortic valve replacement (TAVR). METHODS: We used National Inpatient Sample (NIS) data 2011-2014 to identify patients undergoing TAVR. Association between sleep apnea and in-hospital postoperative outcomes were assessed by multivariate logistic regression and 1:1 propensity score matching analyses. RESULTS: Of 42,189 patients who received TAVR, 4,605 patients (10.9%) had sleep apnea. Patients with sleep apnea were more likely to be younger and male with higher prevalences of hypertension, diabetes mellitus, dyslipidemia, chronic kidney disease, pulmonary hypertension and obesity who less frequently received transapical access than those without sleep apnea. The group with sleep apnea had less bleeding requiring transfusion (8.6% vs. 11.9%, P=0.01) than the counterpart. After adjusting for confounders, the presence of sleep apnea was no longer independently associated with any of the studied outcomes including all-cause mortality (OR 0.95; 95% CI: 0.64-1.42), stroke (OR 1.08; 95% CI: 0.65-1.81), myocardial infarction (OR 0.66; 95% CI: 0.36-1.22), acute respiratory failure (OR 0.94; 95% CI: 0.72-1.23), pneumothorax (OR 0.64; 95% CI: 0.26-1.59), vascular complication (OR 0.91; 95% CI: 0.69-1.22), bleeding requiring transfusion (OR 0.85; 95% CI: 0.65-1.11), acute kidney injury requiring hemodialysis (OR 0.94; 95% CI: 0.53-1.66) and permanent pacemaker implantation (OR 1.12; 95% CI: 0.87-1.43). The length and cost of hospital stay were not affected by sleep apnea, either. CONCLUSIONS: With a prevalence of 10.9%, the presence of sleep apnea was not independently associated with postoperative in-hospital outcomes in patients undergoing TAVR in NIS data 2011 to 2014.
Authors: Craig R Smith; Martin B Leon; Michael J Mack; D Craig Miller; Jeffrey W Moses; Lars G Svensson; E Murat Tuzcu; John G Webb; Gregory P Fontana; Raj R Makkar; Mathew Williams; Todd Dewey; Samir Kapadia; Vasilis Babaliaros; Vinod H Thourani; Paul Corso; Augusto D Pichard; Joseph E Bavaria; Howard C Herrmann; Jodi J Akin; William N Anderson; Duolao Wang; Stuart J Pocock Journal: N Engl J Med Date: 2011-06-05 Impact factor: 91.245
Authors: Stephen A O'Connor; Marie-Claude Morice; Martine Gilard; Martin B Leon; John G Webb; Danny Dvir; Josep Rodés-Cabau; Corrado Tamburino; Davide Capodanno; Fabrizio D'Ascenzo; Philippe Garot; Bernard Chevalier; Ghada W Mikhail; Peter F Ludman Journal: J Am Coll Cardiol Date: 2015-07-21 Impact factor: 24.094
Authors: David D M Nicholl; Sofia B Ahmed; Andrea H S Loewen; Brenda R Hemmelgarn; Darlene Y Sola; Jaime M Beecroft; Tanvir C Turin; Patrick J Hanly Journal: Chest Date: 2012-01-05 Impact factor: 9.410
Authors: Alec Vahanian; Ottavio Alfieri; Felicita Andreotti; Manuel J Antunes; Gonzalo Barón-Esquivias; Helmut Baumgartner; Michael Andrew Borger; Thierry P Carrel; Michele De Bonis; Arturo Evangelista; Volkmar Falk; Bernard Lung; Patrizio Lancellotti; Luc Pierard; Susanna Price; Hans-Joachim Schäfers; Gerhard Schuler; Janina Stepinska; Karl Swedberg; Johanna Takkenberg; Ulrich Otto Von Oppell; Stephan Windecker; Jose Luis Zamorano; Marian Zembala Journal: Eur J Cardiothorac Surg Date: 2012-08-25 Impact factor: 4.191